Detalles de la búsqueda
1.
Capecitabine or Capecitabine Plus Oxaliplatin Versus Fluorouracil Plus Cisplatin in Definitive Concurrent Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma (CRTCOESC): A Multicenter, Randomized, Open-Label, Phase 3 Trial.
J Clin Oncol;
: JCO2302009, 2024 May 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38710003
2.
Nimotuzumab plus concurrent chemo-radiotherapy in unresectable locally advanced oesophageal squamous cell carcinoma (ESCC): interim analysis from a Phase 3 clinical trial.
Br J Cancer;
129(11): 1787-1792, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37864049
3.
Real-World Efficacy and Safety of Sintilimab-Based Regimens against Advanced Esophageal Cancer: A Single-Center Retrospective Observational Study.
Biomed Res Int;
2022: 7331687, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36033564
4.
Deep Learning for Automated Contouring of Gross Tumor Volumes in Esophageal Cancer.
Front Oncol;
12: 892171, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35924169
5.
Development and Validation of a Nomogram for Predicting Overall Survival to Concurrent Chemoradiotherapy in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma.
Biomed Res Int;
2022: 6455555, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35872847
6.
Comparative clinical studies of primary chemoradiotherapy versus S-1 and nedaplatin chemotherapy against stage IVb oesophageal squamous cell carcinoma: a multicentre open-label randomised controlled trial.
BMJ Open;
12(4): e055273, 2022 04 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-35470188
7.
Comparison of concurrent chemoradiotherapy with radiotherapy alone for locally advanced esophageal squamous cell cancer in elderly patients: A randomized, multicenter, phase II clinical trial.
Int J Cancer;
151(4): 607-615, 2022 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35419831
8.
Identification of crucial long non-coding RNAs and mRNAs along with related regulatory networks through microarray analysis in esophageal carcinoma.
Funct Integr Genomics;
21(3-4): 377-391, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33864185
9.
Definition and risk factors of early recurrence based on affecting prognosis of esophageal squamous cell carcinoma patients after radical resection.
Transl Oncol;
14(6): 101066, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33744728
10.
Chemoradiotherapy with extended nodal irradiation and/or erlotinib in locally advanced oesophageal squamous cell cancer: long-term update of a randomised phase 3 trial.
Br J Cancer;
123(11): 1616-1624, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32958820
11.
NR2F1-induced NR2F1-AS1 promotes esophageal squamous cell carcinoma progression via activating Hedgehog signaling pathway.
Biochem Biophys Res Commun;
519(3): 497-504, 2019 11 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31530388
12.
Clinical significance of detecting circulating tumor cells in patients with esophageal squamous cell carcinoma by EpCAMindependent enrichment and immunostainingfluorescence in situ hybridization.
Mol Med Rep;
20(2): 1551-1560, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31257510
13.
Dosimetric comparison of TomoDirect, helical tomotherapy, VMAT, and ff-IMRT for upper thoracic esophageal carcinoma.
Med Dosim;
44(2): 167-172, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-29950277
14.
Randomised phase III trial of concurrent chemoradiotherapy with extended nodal irradiation and erlotinib in patients with inoperable oesophageal squamous cell cancer.
Eur J Cancer;
93: 99-107, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29494818
15.
Systemic Inflammation Biomarkers Predict Survival in Patients of Early Stage Non-Small Cell Lung Cancer Treated With Stereotactic Ablative Radiotherapy - A Single Center Experience.
J Cancer;
9(1): 182-188, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29290784
16.
Prognostic and predictive role of COX-2, XRCC1 and RASSF1 expression in patients with esophageal squamous cell carcinoma receiving radiotherapy.
Oncol Lett;
13(4): 2549-2556, 2017 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-28454432
17.
Effects of nitrosation on the formation of cyanide in publicly owned treatment works secondary effluent.
Water Environ Res;
76(3): 197-204, 2004.
Artículo
en Inglés
| MEDLINE | ID: mdl-15338690
18.
Effects of thiocyanate on the formation of free cyanide during chlorination and ultraviolet disinfection of publicly owned treatment works secondary effluent.
Water Environ Res;
76(3): 205-12, 2004.
Artículo
en Inglés
| MEDLINE | ID: mdl-15338691
19.
The occurrence of cyanide formation in six full-scale publicly owned treatment works.
Water Environ Res;
76(2): 101-12, 2004.
Artículo
en Inglés
| MEDLINE | ID: mdl-15168841
20.
Formation of free cyanide and cyanogen chloride from chloramination of publicly owned treatment works secondary effluent: laboratory study with model compounds.
Water Environ Res;
76(2): 113-20, 2004.
Artículo
en Inglés
| MEDLINE | ID: mdl-15168842